Liver transplantation for non-hepatocellular carcinoma malignancies

Liver Transplantation

Volumn 16, Issue SUPPL. 2, 2010, Pages

  Gores, Gregory J ^a   Heimbach, Julie K ^a   Rosen, Charles B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; COLORECTAL CANCER; HEMANGIOENDOTHELIOMA; LIVER TRANSPLANTATION; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL;

EID: 78651408565     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22145     Document Type: Article

References (14)

1. Foss A, Adam R, Dueland S., Liver transplantation for colorectal liver metastases: revisiting the concept. Transpl Int 2010; 23: 679-685.
2. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006; 107: 2108-2121. (Pubitemid 44665643)
3. Emamaullee JA, Edgar R, Toso C, Thiesen A, Bain V, Bigam D, et al. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: implications for treatment and surgical management. Liver Transpl 2010; 16: 191-197.
4. Rodriguez JA, Becker NS, O'Mahony CA, Goss JA, Aloia TA., Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg 2008; 12: 110-116.
5. Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, et al. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European Liver Transplant Registry. Ann Surg 2007; 246: 949-957. (Pubitemid 350179178)
6. Yao JC, Lombard-Bohas C, Baudin E, Kvols LK, Rougier P, Ruszniewski P, et al. Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. J Clin Oncol 2010; 28: 69-76.
7. Le Treut YP, Gregoire E, Belghiti J, Boillot O, Soubrane O, Mantion G, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant 2008; 8: 1205-1213. (Pubitemid 351763685)
8. Mazzaferro V, Pulvirenti A, Coppa J., Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol 2007; 47: 460-466. (Pubitemid 47331755)
9. van Vilsteren FG, Baskin-Bey ES, Nagorney DM, Sanderson SO, Kremers WK, Rosen CB, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl 2006; 12: 448-456.
10. Everhart JE, Ruhl CE., Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology 2009; 136: 1134-1144.
11. Ghali P, Marotta PJ, Yoshida EM, Bain VG, Marleau D, Peltekian K, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 2005; 11: 1412-1416. (Pubitemid 43071591)
12. Gores GJ, Nagorney DM, Rosen CB., Cholangiocarcinoma: is transplantation an option? For whom? J Hepatol 2007; 47: 455-459.
13. Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ., Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 2009; 18: 325-337.
14. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242: 451-458.